Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
Kate E. Bailey, Guy A. MacGowan, Simon Tual-Chalot, Lauren Phillips, Timothy J. Mohun, Deborah J. Henderson, Helen M. Arthur, Simon D. Bamforth, Helen M. Phillips
Kate E. Bailey, Guy A. MacGowan, Simon Tual-Chalot, Lauren Phillips, Timothy J. Mohun, Deborah J. Henderson, Helen M. Arthur, Simon D. Bamforth, Helen M. Phillips
View: Text | PDF | Retraction
Research Article Cardiology

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy

  • Text
  • PDF
Abstract

Sarcomeric disarray is a hallmark of gene mutations in patients with hypertrophic cardiomyopathy (HCM). However, it is unknown when detrimental sarcomeric changes first occur and whether they originate in the developing embryonic heart. Furthermore, Rho kinase (ROCK) is a serine/threonine protein kinase that is critical for regulating the function of several sarcomeric proteins, and therefore, our aim was to determine whether disruption of ROCK signaling during the earliest stages of heart development would disrupt the integrity of sarcomeres, altering heart development and function. Using a mouse model in which the function of ROCK is specifically disrupted in embryonic cardiomyocytes, we demonstrate a progressive cardiomyopathy that first appeared as sarcomeric disarray during cardiogenesis. This led to abnormalities in the structure of the embryonic ventricular wall and compensatory cardiomyocyte hypertrophy during fetal development. This sarcomeric disruption and hypertrophy persisted throughout adult life, triggering left ventricular concentric hypertrophy with systolic dysfunction, and reactivation of fetal gene expression and cardiac fibrosis, all typical features of HCM. Taken together, our findings establish a mechanism for the developmental origin of the sarcomeric phenotype of HCM and suggest that variants in the ROCK genes or disruption of ROCK signaling could, in part, contribute to its pathogenesis.

Authors

Kate E. Bailey, Guy A. MacGowan, Simon Tual-Chalot, Lauren Phillips, Timothy J. Mohun, Deborah J. Henderson, Helen M. Arthur, Simon D. Bamforth, Helen M. Phillips

×

Figure 2

Impaired maturation of the ventricular wall in late fetal and postnatal ROCKDNGata5-Cre mutants.

Options: View larger image (or click on image) Download as PowerPoint
Impaired maturation of the ventricular wall in late fetal and postnatal ...
(A and B) Measurements of the compact myocardial wall were performed on transverse heart sections from E15.5 (n = 12), E16.5 (n = 5), and E17.5 (n = 4) embryos, and P0 (n = 3), P4 (n = 3), P7 (n = 3), and P21 (n = 4) postnatal pups, in both the left ventricle (A) and right ventricle (B), in control and ROCKDNGata5-Cre mutant littermates. During embryonic and postnatal development, generally, the compact myocardium of the control hearts is thicker than in mutant hearts. In particular, in the left ventricle, the control compact myocardium is significantly thicker than in the ROCKDNGata5-Cre mutant compact myocardium at E15.5, P4, P7, and P21 (A); and in the right ventricle it is significantly thicker at E15.5, P7 and P21 (B). From E15.5 to E16.5 in ROCKDNGata5-Cre mutant hearts, myocardial wall thickness increased significantly, in both the left ventricle and right ventricle (red lines), whereas no corresponding significant increase was observed in control hearts (blue lines). (C–F) High-resolution episcopic microscopy imaging at E15.5 showed that ROCKDNGata5-Cre hearts (D and F) displayed an immature thin myocardial wall containing myocardial crypts within the compact myocardium (red arrows F) compared with controls (C and E). n = 10 for each genotype. (G–J) Phenotypic analysis of 4-chamber view sections from postnatal hearts, stained with the histological stain H&E, confirmed that in the ROCKDNGata5-Cre hearts the ventricular wall was visibly thinner and that it also contained myocardial crypts (arrows) at P0 and P21. n = 3 for each genotype at each time point. (K) Trabecular complexity for each heart was assessed by calculating the ratio of trabecular myocardial area to compact myocardium area throughout the ventricles. There were no significant differences between control and mutant hearts during fetal and postnatal development, confirming that ROCKDNGata5-Cre mutants did not have a non-compaction phenotype. E15.5 (n = 8), E17.5 (n = 6), P0, and P21 (n = 3) for each genotype at each time point. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by 1-way ANOVA with Bonferroni’s correction for multiple comparisons. lv/LV, left ventricle; rv/RV, right ventricle. Scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts